 | 89bio, Inc. | |||
| NGM : ETNB || Location: United States | ||||
$9.08+0.2 (+2.25%) |
1.01 M | 8.78 - 9.1 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 11.550 M |
| March 15, 2024 | 11.112 M |
| Feb. 29, 2024 | 10.862 M |
| Feb. 15, 2024 | 10.578 M |
| Jan. 31, 2024 | 9.628 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.50 | -0.50 | 0.97% |
| 09/30/2023 | -0.54 | -0.45 | 16.76% |
| 06/30/2023 | -0.42 | -0.52 | -23.90% |
| 03/31/2023 | -0.53 | -0.54 | -1.48% |
| 12/31/2022 | -0.70 | -0.48 | 31.43% |
ETNB Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 95.225M | Shares Float | 68.094M |
| Short Float | 11.550M | Market Cap | 864.64M |
| Institution ownership | 0.00% | Insider ownership | 0.841% |
| Earnings Date | 05/08/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -2.00 | Forward EPS | -2.61 |